Text Size

Effects of Emotional Stimulation on the Stress Levels of Healthy Persons

This study has been completed.
Sponsor:
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01187797
First received: August 9, 2010
Last updated: October 22, 2010
Last verified: August 2010
History of Changes
  Purpose

The purpose of this study is to evaluate the effects of a short-term emotional stimulation on the mood of healthy persons.


Condition Intervention Phase
Depression
Somatization Disorder
Anger
Anxiety
 Other: Emotional stimulation
 Phase 1
Phase 2

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Evaluation of the Effects of a Body-centered Emotional Stimulation in Healthy Persons

Resource links provided by NLM:

MedlinePlus related topics: Anxiety Depression
U.S. FDA Resources

Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Depression [ Time Frame: After 10 days ] [ Designated as safety issue: No ]
    Depression scores will be evaluated with the BDI

  • Somatization [ Time Frame: After 10 days ] [ Designated as safety issue: No ]
    Somatization will be assessed with the SOMS7 questionnaire


Enrollment: 21
Study Start Date: August 2010
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Intervention Other: Emotional stimulation
Increase of the physical correlates of an emotion

Detailed Description:

The trial assesses the effects of a emotion-centered stimulation on the mood of healthy persons. The outcomes will be evaluated with standard questionnaires.

  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age 18 to 45
  • Ability to speak German

Exclusion Criteria:

  • Physical or psychiatric disorders
  • Consume of drugs or alcohol 24 previous to the test
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01187797

Locations
Germany
Charité Universitätsmedizin Berlin
Berlin, Germany, 12200
Sponsors and Collaborators
Charite University, Berlin, Germany
Investigators
Principal Investigator: fernando Dimeo, MD Charite University, Berlin, Germany
  More Information

No publications provided

Responsible Party: Fernando Dimeo, Charie Universitätsmedizin Berlin
ClinicalTrials.gov Identifier: NCT01187797     History of Changes
Other Study ID Numbers: EA408109
Study First Received: August 9, 2010
Last Updated: October 22, 2010
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Anxiety Disorders
Depression
Depressive Disorder
Somatoform Disorders
 Mental Disorders
Behavioral Symptoms
Mood Disorders

ClinicalTrials.gov processed this record on May 22, 2013